Literature DB >> 33608386

A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.

Hongchen Cai1, Su Kit Chew2, Chuan Li3, Min K Tsai1, Laura Andrejka1, Christopher W Murray4, Nicholas W Hughes1, Emily G Shuldiner3, Emily L Ashkin4, Rui Tang1, King L Hung4, Leo C Chen1, Shi Ya C Lee2, Maryam Yousefi1, Wen-Yang Lin1, Christian A Kunder5, Le Cong1,5, Christopher D McFarland3, Dmitri A Petrov6,4, Charles Swanton7,8, Monte M Winslow9,4,5.   

Abstract

Cancer genotyping has identified a large number of putative tumor suppressor genes. Carcinogenesis is a multistep process, but the importance and specific roles of many of these genes during tumor initiation, growth, and progression remain unknown. Here we use a multiplexed mouse model of oncogenic KRAS-driven lung cancer to quantify the impact of 48 known and putative tumor suppressor genes on diverse aspects of carcinogenesis at an unprecedented scale and resolution. We uncover many previously understudied functional tumor suppressors that constrain cancer in vivo. Inactivation of some genes substantially increased growth, whereas the inactivation of others increases tumor initiation and/or the emergence of exceptionally large tumors. These functional in vivo analyses revealed an unexpectedly complex landscape of tumor suppression that has implications for understanding cancer evolution, interpreting clinical cancer genome sequencing data, and directing approaches to limit tumor initiation and progression. SIGNIFICANCE: Our high-throughput and high-resolution analysis of tumor suppression uncovered novel genetic determinants of oncogenic KRAS-driven lung cancer initiation, overall growth, and exceptional growth. This taxonomy is consistent with changing constraints during the life history of cancer and highlights the value of quantitative in vivo genetic analyses in autochthonous cancer models.This article is highlighted in the In This Issue feature, p. 1601. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33608386      PMCID: PMC8292166          DOI: 10.1158/2159-8290.CD-20-1325

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  78 in total

1.  Mutational inactivation of STAG2 causes aneuploidy in human cancer.

Authors:  David A Solomon; Taeyeon Kim; Laura A Diaz-Martinez; Joshlean Fair; Abdel G Elkahloun; Brent T Harris; Jeffrey A Toretsky; Steven A Rosenberg; Neerav Shukla; Marc Ladanyi; Yardena Samuels; C David James; Hongtao Yu; Jung-Sik Kim; Todd Waldman
Journal:  Science       Date:  2011-08-19       Impact factor: 47.728

2.  Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia.

Authors:  Bon-Kyoung Koo; Johan H van Es; Maaike van den Born; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-28       Impact factor: 11.205

3.  Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.

Authors:  Xiaomo Jiang; Huai-Xiang Hao; Joseph D Growney; Steve Woolfenden; Cindy Bottiglio; Nicholas Ng; Bo Lu; Mindy H Hsieh; Linda Bagdasarian; Ronald Meyer; Timothy R Smith; Monika Avello; Olga Charlat; Yang Xie; Jeffery A Porter; Shifeng Pan; Jun Liu; Margaret E McLaughlin; Feng Cong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

4.  STAG2 promotes error correction in mitosis by regulating kinetochore-microtubule attachments.

Authors:  Marianna Kleyman; Lilian Kabeche; Duane A Compton
Journal:  J Cell Sci       Date:  2014-07-29       Impact factor: 5.285

5.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

6.  Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

Authors:  Cristina Balbás-Martínez; Ana Sagrera; Enrique Carrillo-de-Santa-Pau; Julie Earl; Mirari Márquez; Miguel Vazquez; Eleonora Lapi; Francesc Castro-Giner; Sergi Beltran; Mònica Bayés; Alfredo Carrato; Juan C Cigudosa; Orlando Domínguez; Marta Gut; Jesús Herranz; Núria Juanpere; Manolis Kogevinas; Xavier Langa; Elena López-Knowles; José A Lorente; Josep Lloreta; David G Pisano; Laia Richart; Daniel Rico; Rocío N Salgado; Adonina Tardón; Stephen Chanock; Simon Heath; Alfonso Valencia; Ana Losada; Ivo Gut; Núria Malats; Francisco X Real
Journal:  Nat Genet       Date:  2013-10-13       Impact factor: 38.330

7.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

8.  Rapid modelling of cooperating genetic events in cancer through somatic genome editing.

Authors:  Francisco J Sánchez-Rivera; Thales Papagiannakopoulos; Rodrigo Romero; Tuomas Tammela; Matthew R Bauer; Arjun Bhutkar; Nikhil S Joshi; Lakshmipriya Subbaraj; Roderick T Bronson; Wen Xue; Tyler Jacks
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

9.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

10.  Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.

Authors:  Che-Hung Shen; Sun Hye Kim; Sebastian Trousil; Dennie T Frederick; Adriano Piris; Ping Yuan; Li Cai; Lei Gu; Man Li; Jung Hyun Lee; Devarati Mitra; David E Fisher; Ryan J Sullivan; Keith T Flaherty; Bin Zheng
Journal:  Nat Med       Date:  2016-08-08       Impact factor: 53.440

View more
  9 in total

Review 1.  Tutorial: design and execution of CRISPR in vivo screens.

Authors:  Christian J Braun; Andrés Carbonell Adames; Dieter Saur; Roland Rad
Journal:  Nat Protoc       Date:  2022-07-15       Impact factor: 17.021

Review 2.  RNA-binding proteins of COSMIC importance in cancer.

Authors:  Peter S Choi; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

3.  Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.

Authors:  Maryam Yousefi; Gábor Boross; Carly Weiss; Christopher W Murray; Jess D Hebert; Hongchen Cai; Emily L Ashkin; Saswati Karmakar; Laura Andrejka; Leo Chen; Minwei Wang; Min K Tsai; Wen-Yang Lin; Chuan Li; Pegah Yakhchalian; Caterina I Colón; Su-Kit Chew; Pauline Chu; Charles Swanton; Christian A Kunder; Dmitri A Petrov; Monte M Winslow
Journal:  Cancer Res       Date:  2022-04-15       Impact factor: 13.312

4.  Quantitative In Vivo Genetic Analysis Reveals Novel Genetic Determinants of Tumor Initiation, Overall Growth, and Exceptional Growth in KRAS-Driven Lung Cancer.

Authors:  Ji Ruan
Journal:  Glob Med Genet       Date:  2021-10-05

5.  Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment.

Authors:  Giorgia Foggetti; Chuan Li; Hongchen Cai; Dmitri A Petrov; Monte M Winslow; Katerina Politi
Journal:  Mol Cell Oncol       Date:  2022-01-14

6.  A new system for multiplexed mosaic analysis of gene function in the mouse.

Authors:  Hongchen Cai; Monte M Winslow
Journal:  Cell Rep Methods       Date:  2022-09-19

7.  Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma.

Authors:  Chuan Li; Wen-Yang Lin; Monte M Winslow; Hira Rizvi; Hongchen Cai; Christopher D McFarland; Zoe N Rogers; Maryam Yousefi; Ian P Winters; Charles M Rudin; Dmitri A Petrov
Journal:  Cancer Res       Date:  2021-07-02       Impact factor: 12.701

8.  Identification and Validation of Autophagy-Related Gene Nomograms to Predict the Prognostic Value of Patients with Cervical Cancer.

Authors:  Jinqun Jiang; HongYan Xu; YiHao Wang; Hai Lu
Journal:  J Oncol       Date:  2021-06-25       Impact factor: 4.375

9.  Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.

Authors:  Yuhui Wu; Xiaojing Liang; Junjie Ni; Rongjie Zhao; Shengpeng Shao; Si Lu; Weidong Han; Liangliang Yu
Journal:  Front Cell Dev Biol       Date:  2021-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.